Is Acromegaly Hereditary? Genetic Causes Explained
At a Glance
Most cases of acromegaly are sporadic and not hereditary, meaning they are not passed down to children. A small percentage are linked to rare genetic conditions, which are primarily seen in patients diagnosed under age 30 or those with a family history of pituitary tumors.
When you are diagnosed with a pituitary tumor and acromegaly, it is completely natural to look at your children and worry: Will I pass this on to them? Do my kids need to be tested?
The short answer for the vast majority of people is no. Most cases of acromegaly are sporadic, meaning they occur randomly [1]. They are caused by a spontaneous genetic change in a single pituitary cell during your lifetime, not by a genetic trait you inherited from your parents or can pass down to your children [1].
However, a small percentage of cases—especially those diagnosed at a young age—are linked to underlying genetic conditions [2].
When Is Acromegaly Genetic?
Inherited forms of acromegaly are rare, accounting for a small fraction of overall cases. However, they become much more likely if the disease begins in childhood or early adulthood (under age 30) [2]. In fact, nearly 50% of patients who develop growth hormone excess in childhood (pituitary gigantism) have a known genetic cause [3].
When acromegaly runs in families or is part of a genetic condition, it usually falls into one of two categories: isolated pituitary tumors or broader genetic syndromes [4].
Familial Isolated Pituitary Adenoma (FIPA)
In some families, pituitary tumors occur without any other associated health conditions [5]. About 20% of FIPA cases are caused by a mutation in the AIP gene [6]. Acromegaly caused by an AIP mutation tends to start at a younger age, grow more aggressively, and may be more resistant to standard injectable medications (somatostatin analogs) [7][8]. The genetic cause for the remaining 80% of families with FIPA is currently unknown and is still being researched [4].
Genetic Syndromes
Sometimes, a pituitary tumor is just one feature of a wider genetic condition [4]. These rare syndromes include:
- Multiple Endocrine Neoplasia type 1 (MEN1): An inherited disorder that causes tumors in the pituitary gland, parathyroid glands (leading to high blood calcium), and pancreas [9].
- Carney Complex: A rare genetic condition causing specific spotty freckling (often on the lips, eyes, or face), heart tumors, and various endocrine tumors, including pituitary adenomas [10].
- McCune-Albright Syndrome: A rare condition characterized by pituitary tumors, fibrous bone dysplasia (weak areas in bones), and distinct café-au-lait (large coffee-colored) birthmarks [11]. Unlike MEN1 or FIPA, this is caused by a random genetic mutation during early fetal development and is generally not passed from parent to child, but it is an important genetic cause of acromegaly [4].
- X-linked Acrogigantism (X-LAG): A very rare genetic cause of extremely early-onset growth hormone excess, usually presenting in infancy or early childhood [4].
Do My Children Need to Be Tested?
If you have sporadic acromegaly—meaning you have no family history, were diagnosed at an older age, and have no symptoms of other syndromes—routine genetic testing or brain MRIs are generally not recommended for your children [12].
You should consider asking your doctor for a referral to a genetic counselor (a specialist who helps you understand your genetic risks and testing options) if:
- You were diagnosed with a pituitary tumor before age 30 [13].
- You have a family history of pituitary tumors (including other types like prolactinomas or Cushing’s disease) or other endocrine gland issues [2]. It helps to gather as much family medical history as possible before your appointment.
- You have symptoms of a broader genetic syndrome, such as unusual skin spots, persistent high blood calcium, or kidney stones [9][11].
If your doctor or genetic counselor determines there is a risk of a hereditary condition, the first step is testing you, not your children [14]. A blood or saliva test can check your DNA for known mutations, such as in the AIP or MEN1 genes [14][15]. (Note: Genetic testing ordered by a medical professional for clinical reasons is often covered by insurance, but it is always best to check with your provider and the counselor beforehand.)
If your genetic test reveals a hereditary mutation, your medical team will then discuss the possibility of testing your children [3]. It is important to know that incomplete penetrance is common in these conditions—this means that even if a child inherits a gene mutation like AIP, it does not guarantee they will ever actually develop a pituitary tumor.
If a child is found to carry a genetic mutation, their doctor may recommend periodic screening—such as checking their height, measuring IGF-1 levels in their blood, or occasionally doing a pituitary MRI—to catch any potential tumor early before it causes harm [16].
What Signs Should I Watch For?
In adults, growth hormone excess causes acromegaly (thickening of bones, hands, feet, and facial features). Because children’s growth plates are still open, excessive growth hormone causes pituitary gigantism instead [3].
If a child were to develop a growth hormone-secreting tumor, the primary sign is an abnormally rapid growth spurt—shooting up much faster than their peers or crossing multiple percentiles on their growth chart [3]. If you notice this accelerated growth, bring it up with their pediatrician and mention your personal history of a pituitary tumor.
Common questions in this guide
Is acromegaly passed down from parents to children?
When should I consider genetic testing for acromegaly?
Do my children need to be tested for acromegaly?
What signs of a pituitary tumor should I watch for in my children?
What is Familial Isolated Pituitary Adenoma (FIPA)?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my age at diagnosis and tumor characteristics, do you recommend I be evaluated by a genetic counselor?
- 2.Are there any other health screenings I should undergo to rule out genetic syndromes like MEN1?
- 3.What specific growth patterns or symptoms should I watch for in my children?
- 4.If I am tested and a genetic mutation is found, what would the specific screening protocol and timeline look like for my kids?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Low frequency of AIP mutations in patients with young-onset sporadic pituitary macroadenomas.
Gaspar LM, Gonçalves CI, Saraiva C, et al.
Journal of endocrinological investigation 2023; (46(11)):2299-2307 doi:10.1007/s40618-023-02083-7.
PMID: 37149543 - 2
AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience.
Ramírez-Rentería C, Hernández-Ramírez LC, Portocarrero-Ortiz L, et al.
Endocrine 2016; (53(2)):402-11 doi:10.1007/s12020-016-0930-9.
PMID: 27033541 - 3
The causes and consequences of pituitary gigantism.
Beckers A, Petrossians P, Hanson J, Daly AF
Nature reviews. Endocrinology 2018; (14(12)):705-720 doi:10.1038/s41574-018-0114-1.
PMID: 30361628 - 4
Genetics of gigantism and acromegaly.
Hannah-Shmouni F, Trivellin G, Stratakis CA
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2016; (30-31()):37-41 doi:10.1016/j.ghir.2016.08.002.
PMID: 27657986 - 5
[Tumor predisposition in endocrinology - from MEN to FIPA].
Jegodzinski L, Gebauer J
Deutsche medizinische Wochenschrift (1946) 2024; (149(6)):283-289 doi:10.1055/a-2131-2450.
PMID: 38412983 - 6
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA).
Vasilev V, Daly AF, Trivellin G, et al.
Endocrine-related cancer 2020; (27(8)):T77-T86.
PMID: 32083999 - 7
Germline AIP variants in sporadic young acromegaly and pituitary gigantism: clinical and genetic insights from a Han Chinese cohort.
Xiang B, Zhang X, Liu W, et al.
Endocrine 2024; (85(3)):1346-1356 doi:10.1007/s12020-024-03898-x.
PMID: 38851643 - 8
Pituitary Disease in AIP Mutation-Positive Familial Isolated Pituitary Adenoma (FIPA): A Kindred-Based Overview.
Bilbao Garay I, Daly AF, Egaña Zunzunegi N, Beckers A
Journal of clinical medicine 2020; (9(6)) doi:10.3390/jcm9062003.
PMID: 32604740 - 9
Paediatric and young adult manifestations and outcomes of multiple endocrine neoplasia type 1.
Herath M, Parameswaran V, Thompson M, et al.
Clinical endocrinology 2019; (91(5)):633-638 doi:10.1111/cen.14067.
PMID: 31348545 - 10
Updated Recommendations for Pediatric Surveillance in Hereditary Endocrine Neoplasia Syndromes: Multiple Endocrine Neoplasias, Hyperparathyroidism-Jaw Tumor Syndrome, and Carney Complex.
Wasserman JD, Schneider KW, Achatz MI, et al.
Clinical cancer research : an official journal of the American Association for Cancer Research 2025; (31(17)):3628-3637 doi:10.1158/1078-0432.CCR-24-3860.
PMID: 40560659 - 11
McCune-Albright syndrome with multiple hyperfunctional endocrinopathies: diagnosis, treatment, and long-term follow-up: a case report.
Zainab MJ, Khamies LL, Baladi J, et al.
Frontiers in endocrinology 2025; (16()):1632257 doi:10.3389/fendo.2025.1632257.
PMID: 40917355 - 12
AIP mutations and gigantism.
Rostomyan L, Potorac I, Beckers P, et al.
Annales d'endocrinologie 2017; (78(2)):123-130 doi:10.1016/j.ando.2017.04.012.
PMID: 28483363 - 13
Unusual AIP mutation and phenocopy in the family of a young patient with acromegalic gigantism.
Imran SA, Aldahmani KA, Penney L, et al.
Endocrinology, diabetes & metabolism case reports 2018; (2018()) doi:10.1530/EDM-17-0092.
PMID: 29472986 - 14
From bench to bedside in the sella: translational developments in pituitary tumour genetics.
De Sousa SMC
Endocrine-related cancer 2025; (32(5)).
PMID: 40197437 - 15
Recurrent Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1 Syndrome.
Libánský P, Čarková J, Kushnir I, et al.
Physiological research 2023; (72(S4)):S423-S427 doi:10.33549/physiolres.935223.
PMID: 38116778 - 16
Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening.
Iacovazzo D, Hernández-Ramírez LC, Korbonits M
Expert review of endocrinology & metabolism 2017; (12(2)):143-153 doi:10.1080/17446651.2017.1306439.
PMID: 30063429
This page provides educational information about the genetic risks of acromegaly. It does not replace professional medical advice. Always consult a genetic counselor or endocrinologist regarding your specific family medical history and testing options.
Get notified when new evidence is published on Acromegaly.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.